Selected research
Market Outlook & Growth Opportunities
Global Autism Digital Therapy Market Outlook and Growth Opportunities 2026
Market perspective
The global Autism Digital Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Autism Digital Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Autism Digital Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Autism Digital Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Autism Digital Therapy market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Autism Digital Therapy market include Cognoa, IMUTISM, Impute, HARMAN, Roche, Autism 360, Brightline, EarliTec Diagnostics and SpectrumAi, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Autism Digital Therapy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Autism Digital Therapy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Autism Digital Therapy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Autism Digital Therapy market.
Autism Digital Therapy Segment by Company
Cognoa
IMUTISM
Impute
HARMAN
Roche
Autism 360
Brightline
EarliTec Diagnostics
SpectrumAi
Brain in Hand
Healios
Fumi Health Technology
Autism Digital Therapy Segment by Type
Prevention
Manage
Treat
Others
Autism Digital Therapy Segment by Application
Hospital
Rehabilitation Facility
Family
Others
Autism Digital Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Autism Digital Therapy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Autism Digital Therapy key companies, revenue, market share, and recent developments.
3. To split the Autism Digital Therapy breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Autism Digital Therapy market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Autism Digital Therapy significant trends, drivers, influence factors in global and regions.
6. To analyze Autism Digital Therapy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autism Digital Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Autism Digital Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autism Digital Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Autism Digital Therapy industry.
Chapter 3: Detailed analysis of Autism Digital Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Autism Digital Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Autism Digital Therapy in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Prevention
- Manage
- Treat
- Others
Applications
- Hospital
- Rehabilitation Facility
- Family
- Others
Companies covered
- Cognoa
- IMUTISM
- Impute
- HARMAN
- Roche
- Autism 360
- Brightline
- EarliTec Diagnostics
- SpectrumAi
- Brain in Hand
- Healios
- Fumi Health Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Autism Digital Therapy Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Autism Digital Therapy Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Autism Digital Therapy Market Dynamics
- 2.1 Autism Digital Therapy Industry Trends
- 2.2 Autism Digital Therapy Industry Drivers
- 2.3 Autism Digital Therapy Industry Opportunities and Challenges
- 2.4 Autism Digital Therapy Industry Restraints
3 Autism Digital Therapy Market by Company
- 3.1 Global Autism Digital Therapy Company Revenue Ranking in 2025
- 3.2 Global Autism Digital Therapy Revenue by Company (2021-2026)
- 3.3 Global Autism Digital Therapy Company Ranking (2024-2026)
- 3.4 Global Autism Digital Therapy Company Manufacturing Base and Headquarters
- 3.5 Global Autism Digital Therapy Company Product Type and Application
- 3.6 Global Autism Digital Therapy Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Autism Digital Therapy Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Autism Digital Therapy Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Autism Digital Therapy Market by Type
- 4.1 Autism Digital Therapy Type Introduction
- 4.1.1 Prevention
- 4.1.2 Manage
- 4.1.3 Treat
- 4.1.4 Others
- 4.2 Global Autism Digital Therapy Sales Value by Type
- 4.2.1 Global Autism Digital Therapy Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Autism Digital Therapy Sales Value by Type (2021-2032)
- 4.2.3 Global Autism Digital Therapy Sales Value Share by Type (2021-2032)
5 Autism Digital Therapy Market by Application
- 5.1 Autism Digital Therapy Application Introduction
- 5.1.1 Hospital
- 5.1.2 Rehabilitation Facility
- 5.1.3 Family
- 5.1.4 Others
- 5.2 Global Autism Digital Therapy Sales Value by Application
- 5.2.1 Global Autism Digital Therapy Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Autism Digital Therapy Sales Value by Application (2021-2032)
- 5.2.3 Global Autism Digital Therapy Sales Value Share by Application (2021-2032)
6 Autism Digital Therapy Regional Value Analysis
- 6.1 Global Autism Digital Therapy Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Autism Digital Therapy Sales Value by Region (2021-2032)
- 6.2.1 Global Autism Digital Therapy Sales Value by Region: 2021-2026
- 6.2.2 Global Autism Digital Therapy Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Autism Digital Therapy Sales Value (2021-2032)
- 6.3.2 North America Autism Digital Therapy Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Autism Digital Therapy Sales Value (2021-2032)
- 6.4.2 Europe Autism Digital Therapy Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Autism Digital Therapy Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Autism Digital Therapy Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Autism Digital Therapy Sales Value (2021-2032)
- 6.6.2 South America Autism Digital Therapy Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Autism Digital Therapy Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Autism Digital Therapy Sales Value Share by Country, 2025 VS 2032
7 Autism Digital Therapy Country-level Value Analysis
- 7.1 Global Autism Digital Therapy Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Autism Digital Therapy Sales Value by Country (2021-2032)
- 7.2.1 Global Autism Digital Therapy Sales Value by Country (2021-2026)
- 7.2.2 Global Autism Digital Therapy Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.7.2 France Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.14.2 China Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.17.2 India Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Autism Digital Therapy Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Autism Digital Therapy Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Autism Digital Therapy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Cognoa
- 8.1.1 Cognoa Company Information
- 8.1.2 Cognoa Business Overview
- 8.1.3 Cognoa Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 8.1.4 Cognoa Autism Digital Therapy Product Portfolio
- 8.1.5 Cognoa Recent Developments
- 8.2 IMUTISM
- 8.2.1 IMUTISM Company Information
- 8.2.2 IMUTISM Business Overview
- 8.2.3 IMUTISM Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 8.2.4 IMUTISM Autism Digital Therapy Product Portfolio
- 8.2.5 IMUTISM Recent Developments
- 8.3 Impute
- 8.3.1 Impute Company Information
- 8.3.2 Impute Business Overview
- 8.3.3 Impute Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 8.3.4 Impute Autism Digital Therapy Product Portfolio
- 8.3.5 Impute Recent Developments
- 8.4 HARMAN
- 8.4.1 HARMAN Company Information
- 8.4.2 HARMAN Business Overview
- 8.4.3 HARMAN Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 8.4.4 HARMAN Autism Digital Therapy Product Portfolio
- 8.4.5 HARMAN Recent Developments
- 8.5 Roche
- 8.5.1 Roche Company Information
- 8.5.2 Roche Business Overview
- 8.5.3 Roche Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 8.5.4 Roche Autism Digital Therapy Product Portfolio
- 8.5.5 Roche Recent Developments
- 8.6 Autism 360
- 8.6.1 Autism 360 Company Information
- 8.6.2 Autism 360 Business Overview
- 8.6.3 Autism 360 Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 8.6.4 Autism 360 Autism Digital Therapy Product Portfolio
- 8.6.5 Autism 360 Recent Developments
- 8.7 Brightline
- 8.7.1 Brightline Company Information
- 8.7.2 Brightline Business Overview
- 8.7.3 Brightline Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 8.7.4 Brightline Autism Digital Therapy Product Portfolio
- 8.7.5 Brightline Recent Developments
- 8.8 EarliTec Diagnostics
- 8.8.1 EarliTec Diagnostics Company Information
- 8.8.2 EarliTec Diagnostics Business Overview
- 8.8.3 EarliTec Diagnostics Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 8.8.4 EarliTec Diagnostics Autism Digital Therapy Product Portfolio
- 8.8.5 EarliTec Diagnostics Recent Developments
- 8.9 SpectrumAi
- 8.9.1 SpectrumAi Company Information
- 8.9.2 SpectrumAi Business Overview
- 8.9.3 SpectrumAi Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 8.9.4 SpectrumAi Autism Digital Therapy Product Portfolio
- 8.9.5 SpectrumAi Recent Developments
- 8.10 Brain in Hand
- 8.10.1 Brain in Hand Company Information
- 8.10.2 Brain in Hand Business Overview
- 8.10.3 Brain in Hand Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 8.10.4 Brain in Hand Autism Digital Therapy Product Portfolio
- 8.10.5 Brain in Hand Recent Developments
- 8.11 Healios
- 8.11.1 Healios Company Information
- 8.11.2 Healios Business Overview
- 8.11.3 Healios Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 8.11.4 Healios Autism Digital Therapy Product Portfolio
- 8.11.5 Healios Recent Developments
- 8.12 Fumi Health Technology
- 8.12.1 Fumi Health Technology Company Information
- 8.12.2 Fumi Health Technology Business Overview
- 8.12.3 Fumi Health Technology Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 8.12.4 Fumi Health Technology Autism Digital Therapy Product Portfolio
- 8.12.5 Fumi Health Technology Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst